We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$124B
AUM Growth
+$12.6B
Cap. Flow
+$4.01B
Cap. Flow %
3.23%
Top 10 Hldgs %
24.28%
Holding
4,396
New
293
Increased
2,114
Reduced
1,559
Closed
268

Sector Composition

Rank Sector Weight
1 Technology 15.45%
2 Financials 8.54%
3 Healthcare 8.18%
4 Consumer Discretionary 6.58%
5 Industrials 6.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JOB icon
4001
GEE Group
JOB
$22M
$16K ﹤0.01%
28,000
MFIC icon
4002
CALL
MidCap Financial Investment
MFIC
$800M
$16K ﹤0.01%
+16,300
New +$214K
NGD
4003
DELISTED
New Gold Inc
NGD
$16K ﹤0.01%
10,582
-12,122
-53% -$17.5K
PBT
4004
CALL
Permian Basin Royalty Trust
PBT
$1.54B
$16K ﹤0.01%
+11,500
New +$94.8K
QNTM
4005
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$23.3M
$16K ﹤0.01%
231
MMM icon
4006
CALL
3M
MMM
$94.5B
$15K ﹤0.01%
17,462
+120
+0.7% +$17.9K
RMTI icon
4007
Rockwell Medical
RMTI
$27.9M
$15K ﹤0.01%
327
-113
-26% -$6.05K
XCUR icon
4008
Exicure
XCUR
$8.54M
$15K ﹤0.01%
503
MTNB icon
4009
Matinas BioPharma
MTNB
$1.7M
$14K ﹤0.01%
+270
New +$14.4K
BBY icon
4010
CALL
Best Buy
BBY
$17.7B
$13K ﹤0.01%
55,700
-27,100
-33% -$3.08M
HBAN icon
4011
CALL
Huntington Bancshares
HBAN
$35.8B
$13K ﹤0.01%
66,500
-10,500
-14% -$165K
NXE icon
4012
CALL
NexGen Energy
NXE
$7.08B
$13K ﹤0.01%
16,000
NMTR
4013
DELISTED
9 Meters Biopharma
NMTR
$13K ﹤0.01%
650
OXY icon
4014
CALL
Occidental Petroleum
OXY
$59.4B
$12K ﹤0.01%
20,200
-6,800
-25% -$213K
SYF icon
4015
CALL
Synchrony
SYF
$25.7B
$12K ﹤0.01%
35,500
+16,500
+87% +$793K
MARK
4016
DELISTED
Remark Holdings, Inc.
MARK
$12K ﹤0.01%
1,170
CCI icon
4017
PUT
Crown Castle
CCI
$31.6B
$11K ﹤0.01%
+11,100
New +$2.05M
CTRA
4018
CALL
DELISTED
Coterra Energy
CTRA
$11K ﹤0.01%
+21,400
New +$446K
TOON icon
4019
Kartoon Studios
TOON
$35.7M
$11K ﹤0.01%
1,070
-151
-12% -$1.97K
MRO
4020
CALL
DELISTED
Marathon Oil Corporation
MRO
$11K ﹤0.01%
+62,200
New +$1,000K
REGI
4021
CALL
DELISTED
Renewable Energy Group, Inc.
REGI
$11K ﹤0.01%
+21,600
New +$1.1M
ALK icon
4022
CALL
Alaska Air
ALK
$5.45B
$10K ﹤0.01%
38,900
+3,500
+10% +$189K
ENB icon
4023
CALL
Enbridge
ENB
$113B
$10K ﹤0.01%
35,200
-15,900
-31% -$638K
HEXO
4024
DELISTED
HEXO Corp. Common Shares
HEXO
$10K ﹤0.01%
1,012
-109
-10% -$2.02K
RMO
4025
CALL
DELISTED
Romeo Power, Inc.
RMO
$10K ﹤0.01%
+33,300
New +$144K

Similar funds

Raymond James & Associates's Q4 2021 Portfolio in Review

As of Q4 2021, Raymond James & Associates held 4,396 positions worth $124B, up 11% from $111B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates deployed $4.01B of net new capital in Q4 2021, opening 293 new positions and adding to 2,114 existing holdings. Its largest new stake was Wells Fargo 7.5% Non Cumv Perp Conv: 14,614 shares worth $21.8M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI All Country Asia ex Japan ETF, an estimated $80M trimmed.

  • Raymond James & Associates's largest Q4 2021 buy was Wells Fargo 7.5% Non Cumv Perp Conv: 14,614 shares worth $21.8M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q4 2021, an estimated $212M increase.
  • Raymond James & Associates's biggest Q4 2021 reduction was iShares MSCI All Country Asia ex Japan ETF, cutting an estimated $80M.
  • Raymond James & Associates fully exited Kansas City Southern in Q4 2021, selling an estimated $80.8M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $124B portfolio in Q4 2021.
  • Raymond James & Associates opened 293 new positions and closed 268 in Q4 2021.
  • Raymond James & Associates's portfolio value rose 11% quarter-over-quarter to $124B.

Based on Raymond James & Associates's 13F filing for Q4 2021, filed 8 Feb 2022.